Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting
Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.
Diabetes Technology
Continuous Glucose Monitoring Aids Glycemic Control in Young Adults With Diabetes
Continuous glucose monitoring improves glycemic control in adolescents and young adults with T1D and is beneficial for hypoglycemia in older adults with T1D.
FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes
The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.
Use of CGM at Diabetes Camps May Reduce Hypoglycemia in Campers
Use of continuous glucose monitoring significantly decreases rates of hypoglycemia among children and adolescents who attend diabetes camps.
Using Smartphone Apps for Glycemic Control in Diabetes: What Improvements Are Still Needed?
Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.
Implementing CGM for Hospitalized Patients With COVID-19 and Diabetes: Insights From One Medical Center
In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.
Recommendations for Effective Implementation of Telehealth for Diabetes Care
Experts provide recommendations for effective implementation of telehealth for diabetes care, with a focus on patient-to-clinic video encounters.
Telemedicine for Diabetes Management During the COVID-19 Pandemic and Beyond
Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.
Glycemic Control Good for Regular Human Insulin With V-Go Device
For patients with T2D, glycemic control is similar with use of regular human insulin and rapid-acting insulin when delivered with a wearable insulin delivery device, V-Go.
Real-World Data Analyzed for Use of Insulin Pump System in T1D
Real-world data support the benefit of using the Medtronic MiniMed 670G insulin pump system for glycemic control in type 1 diabetes.
-
Loading...
-
Loading...
Next post in Type 1 Diabetes
